ANDA Sponsors’ Tablets/Capsules Should Hew Close to RLD in Size, Shape

Drug Industry Daily
A A
Generics makers should design tablets and capsules to be similar in size and shape to their reference listed drug (RLD) when they seek ANDA approval, the FDA says.

To View This Article:

Login

Subscribe To Drug Industry Daily